CIGB-258 immunomodulatory peptide for the treatment of critical and severe COVID-19 patients

CIGB-258 immunomodulatory peptide for the treatment of critical and severe COVID-19 patients

Introduction: CIGB-258 is an immunomodulatory peptide with anti-inflammatory properties. Objectives: To establish the therapeutic schedule with CIGB-258 peptide for COVID-19 critically ill patients. In addition, to define the criteria for use and schedule of this peptide for COVID-19 seriously ill p...

Full description

Bibliographic Details
Main Authors: Rafael Venegas Rodríguez, Rubén Peña Ruiz, Raúl Santana Sánchez, Mónica Bequet-Romero, Mabel Hernández-Cedeño, Beatriz Santiesteban Licea, Ariana García, Pedro Rafel Aroche de Dios, Daniela Oliva Pérez, Leticia Rosario Cruz, Idelsis Esquivel Moynelo, Maura García Sánchez, Gillian Martínez-Donato, Gerardo Guillén-Nieto, María del Carmen Domínguez Horta
Format: Article
Language:Spanish
Published: ECIMED 2020-10-01
Series:Revista Cubana de Medicina Militar
Subjects:
covi-19
tormenta de citocinas
hiperinflamación
hsp60
cigb-258
jusvinza.
Online Access:http://www.revmedmilitar.sld.cu/index.php/mil/article/view/926

Internet

http://www.revmedmilitar.sld.cu/index.php/mil/article/view/926

Similar Items